Hepatitis C and HIV Incidence Among Injecting Drug Users in Kabul, Afghanistan Catherine Todd, Abdul Nasir, M. Raza Stanekzai, M. Zafar Rasuli, Katja Fiekert,

Slides:



Advertisements
Similar presentations
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Advertisements

The HIV Situation in the Philippines
CDC-NIMH Conference Closing Meditations Thomas J. Coates PhD Professor of Medicine Director, AIDS Research Institute University of California San Francisco.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
High Risk Sharing Behaviors: The Effect of Sex within Injecting Partnerships Meghan D. Morris, PhD, MPH Postdoctoral Research Fellow Department of Epidemiology.
Killing the Pain: Prescription Drug Abuse and Other Risky Behaviors in Rural Appalachia Jennifer R. Havens, PhD, MPH Department of Behavioral Science Center.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Can community based HIV prevention have a positive effect on HIV testing behavior? Findings from a quasi- experimental study with female sex workers in.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Efficacy of a Peer-Led Network Intervention in Reducing HIV Incidence among People Who Inject Drugs in Ukraine: Preliminary Results from a Clustered Randomized.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV and drug prevention in Estonia Harm reduction services
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Men at higher risk Last updated: March 2015.
Annual report 2010: the state of the drugs problem in Europe.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Essential package of targeted interventions for MARA Romania Experience.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Olivia Chang, MPH Research and Program Manager Pangaea Global AIDS
Pennsylvania: The State of HCV 2015
HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan Last updated: December 2014.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
HIV/AIDS AND THE ECONOMIC DEMOGRAPHY OF TSHWANE Prof Carel van Aardt Bureau of Market Research.
Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? 1. Julius Center, University.
Drug users in Amsterdam: are they still at risk for HIV? Nienke van der Knaap, Bart Grady, Maarten Schim van der Loeff, Titia Heijman, Arjen Speksnijder,
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Jennifer R. Havens, PhD, MPH Associate Professor
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Bhutan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Lao PDR Last updated: July 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Other women and men at higher risk Last updated: November 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Prisoners Last updated: November 2015.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
Co-infections of Hepatitis C or Tuberculosis Among Persons Living with HIV in The Florida Cohort Project Alexander Zirulnik MPH, Chukwuemeka Okafor MPH,
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
High HIV, HBV and HCV Prevalence among People Who Inject Drugs: Results from the First Integrated Bio-behavioral Survey of PWID in Mozambique Authors:
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Readiness To Change HIV/HCV Risk Behavior Among Young African American IDUs. Edward V Morse, PhD, Tulane University Health Sciences Center, Department.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: April 2016.
Role of Ministry of Health and Medical Education in management and control of Hepatitis C 2016/07/13.
Characterizing the HIV Epidemic in the Middle East The MENA HIV/AIDS Epidemiology and Response Synthesis Project is financed as a joint activity by the.
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
Key Population Community taking the Lead.
Injecting Drug Users and HIV/AIDS in Pakistan
Government of Swaziland
HIV prevalence (%) trends among injecting drug users
Hepatitis C Incidence and Prevalence in the U.S.
Reitox National Focal Point National Bureau for Drug Prevention
People who inject drugs
The HIV Epidemic among People who Inject Drugs
2018 Postgraduate Research Symposium: Exploring opportunities
HA-REACT Joint Action WP4 Testing and Linkage to care Methods:
Summary Sheet Figures and Maps
Share your thoughts on this presentation with #IAS2019
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Hepatitis C and HIV Incidence Among Injecting Drug Users in Kabul, Afghanistan Catherine Todd, Abdul Nasir, M. Raza Stanekzai, M. Zafar Rasuli, Katja Fiekert, Mark Orr, Steffanie Strathdee, & David Vlahov

BACKGROUND & DESIGN Opiate production & use in Afghanistan at high levels with injecting use concentrated in urban areas. 1 Kabul has population of 4 million with estimated 1251 injecting drug users in Study was longitudinal cohort assessing trends in risk behaviors & HIV, syphilis, & hepatitis B & C infection over a 24 month period. Participants completed questionnaire at baseline, quarterly in 1 st year, & semi-annually in 2 nd year. Serologic testing performed with whole blood rapid testing & serum-based confirmatory tests at baseline & every 6 months. References: 1.UNODC. Drug Use in Afghanistan: 2009 Survey. Executive summary. UNODC, 2010, Vienna, Austria. 2.SAR AIDS Human Development Sector, South Asia Region, The World Bank. Mapping and Situation Assessment of Key Populations at High Risk of HIV in Three Cities of Afghanistan. Available at: PHEANUT/EXTSAREGTOPHIVAIDS/0,,contentMDK: ~pagePK: ~piPK: ~theSitePK:496967,00.html

FEATURES/KEY EVENTS OF COHORT

INCIDENCE & RISK FACTORS - At 6 months, HIV acquisition associated with sharing syringes in last 6 months & duration of injecting; HCV seroconversion not associated with any variable. - At 12 months, HIV acquisition remained associated with duration of injecting & sharing syringe sharing. HCV acquisition was associated with age while younger age at initiation of injecting was protective.

LIMITATIONS 97 participants presented only at enrollment; those with no follow-up had lower HCV prevalence at baseline (18.8% vs. 40.4%, p<0.001) and were more likely to be new initiates (<1 year) of injecting drug use (29.7% vs. 17.2, p=0.04). Deaths likely under-reported as no official reporting system.

CLOSING THOUGHTS Two years ago the services were same but their services were very weak. Two years ago, you had wait for hours for one syringe. Now they expanded their services a lot and also have improved a lot. Now they have fixed times for distribution of syringes. The drug users can take syringes on time. They provide the service of taking a bath for drug users and also they give food for drug users. When they (drug users) leave, they are given one week supply of syringes which is 30 syringes. IDI 006 Yes, of course HR program has reduced risk. Before these programs, drug users shared syringes. Now everyone uses one syringe one time. Besides harm reduction programs help with the treatment of different diseases such as: HIV, Hepatitis, syphilis etc. IDI 209

ACKNOWLEDGEMENTS We wish to thank the Ministries of Public Health and Counter-Narcotics of the Islamic Republic of Afghanistan and our harm reduction partners, Medicins du Monde, Nejat Center, and OTCD, for their assistance; and, especially, our participants for their time and trust. This study was funded by the Doris Duke Charitable Foundation with confirmatory testing support provided by the U.S. Military HIV Research Program. CT also appreciates support from the Fogarty International Center of the National Institutes of Health (K01TW007408).